期刊文献+

曲安奈德球筋膜下注射治疗Vogt-小柳-原田病黄斑区浆液性视网膜脱离临床研究 被引量:3

Clinic effect on macular serous retinal detachment of Vogt-Koyanagi-Harada (VKH) disease by injecting triamcinolone acetonide (TA) under Tenon's
原文传递
导出
摘要 目的观察曲安奈德(TA)球筋膜下(Tenon囊)注射联合全身糖皮质激素治疗Vogt-小柳-原田氏病(VKH)的浆液性视网膜脱离的效果。方法于2010年5月至2011年10月在眼科门诊就诊的Vogt—小柳-原田病患者23例46只眼,随机分为两组,对照组(22只眼)单纯给予糖皮质激素治疗;观察组(24只眼)糖皮质激素联合曲安奈德球筋膜下注射治疗。两组患者分别在治疗前及治疗后1周、1个月、3个月、6个月常规检查裸眼视力、最佳矫正视力、眼前节检查、眼底荧光血管造影(FFA)和光学相干断层扫描(OCT)检查,并对数据进行分析。结果治疗后不同时期,观察组视力提高水平均较对照组高;治疗3个月后两组患者荧光血管造影图像的比较,观察组有效率(91.6%)高于对照组(63.6%),差异有统计学意义(x2=5.3008,P=0.021)。治疗后黄斑区视网膜神经上皮层的厚度,观察组为(151±53)μm,对照组为(283±67)μm,两组差别有统计学意义(P=0.000)。患者视力和视网膜神经上皮层厚度进行相关性分析(r=-0.897,P=0.000);视力水平和神经上皮层厚度呈显著负相关。结论全身大剂量糖皮质激素联合曲安奈德球筋膜下注射可以促进黄斑区视网膜下积液迅速吸收,恢复视功能,缩短治疗时间。 Objective To observe the clinic effect of Vogt-Koyanagi-Harada (VKH) disease by injecting triamcinolone acetonide (TA) under Tenon' s. Methods Forty-six eyes of 23 consecutive patients diagnosed with diagnosed with acute VKH disease in our department of ophthalmology from May 2010 to October 2011. All the patients were divided into 2 groups: control group (22 eyes) were given pmethylprednisolone and observed group (24 eyes) were given pmethylprednisolone com- bined with TA injection under Tenon' s. All the patients were performed no-corrected visual activity, best corrected visual activity, slitlamp check, fundus photograph and spectral-domain optical coherence tomography (OCT) at the initial visit and 1 week, 1 month, 3 months, and 6 months after steroid treatment. All the data were analyzed by SPSS 13.0. Results After the treatment, the VA improved levels was higher in observed group than in control group. After treatment 3 months, the FFA of VKH disease showed the effective was higher in observed group (91.6%) than in control group (63.6%), there was significantly difference between the two groups (g2=5.3008, P =0.021). The thickness of fovea was (151±53)μm in observed group and (283±67)μm in control group, there was significantly difference between the two groups (P =000). There was statistically significant correlation between the vision activity with the thickness of serous retinal detachment (r =-0.897, P = 0.000). Conclusions The patients with VHK disease treated by pmethylprednisolone combined with TA injection under Tenon's can enhance the clinic effect and reduce the treatment time.
作者 杨世琳 郭莹
出处 《中国实用眼科杂志》 CSCD 北大核心 2013年第5期575-577,共3页 Chinese Journal of Practical Ophthalmology
关键词 VOGT-小柳-原田病 曲安奈德 糖皮质激素 TENON囊 VVogt-Koyanagi-Harada disease Triamcinolone acetonide Pmethylprednisolone Ten- on' s capsula
  • 相关文献

参考文献12

  • 1杨培增著..临床葡萄膜炎[M].北京:人民卫生出版社,2004:757.
  • 2RaoNA,Sukavatchsrin S,Tsai JH Vogt-Koyanagi-Harada dis-e^e diagnostic criteria[J] Int Ophthalr&ol,2007,27: 195-199. 被引量:1
  • 3Read RW,Holland GN, Rao NA, et al International Committeeon Vogt-Koyanagi-Harada disease Nomenclature Revised di?^-nostie criteria for Vogt-Koyanagi-Harada disease report of aninternational committee on nomenclature [J] Am J Ophthalmol,2001,131:647-652. 被引量:1
  • 4史雪辉,杨丽红,丁宁,田蓓,魏文斌.Vogt-小柳-原田综合征葡萄膜炎期荧光素钠及吲哚菁绿同步眼底血管造影特征分析[J].眼科新进展,2011,31(10):941-944. 被引量:5
  • 5RothovaA Inflammatory cystoid macularedema [J] Curr OpinOphthalmol, 2007,18(6) :487-92. 被引量:1
  • 6Roesel M,Heimes B,Heinz C,et al Comparison of retind thick-ness and fundus-related microperimelry with visual acuity inuveitic macula oedema [J] Acta Ophthalmol, 2011, 89 (6):533-7. 被引量:1
  • 7Nunes S,Pereira I,Santos A, et al Central retinal thicknessme^ured with HD—OCT shows a weak correlation with visualacuity in eyes with CSME[J] Br J Ophthalmol,2010,94(9):1201-4. 被引量:1
  • 8Siva併細d S’Ikeji F,Xing Wtet al Tomographic assessment <dtherapeutic response to uveitic macular [J] Clin ExperimentOphthalmol,2007,35(8):719-23. 被引量:1
  • 9李漫丽,牛超,王志立,武文忠,王丽娅.频域OCT定性定量分析葡萄膜炎性黄斑水肿[J].中国实用眼科杂志,2012,30(2):112-115. 被引量:4
  • 10Couch SM, Bakri SJ Intravitreal triamcinolone for intraocular infi^nmation and associated macular edema [J] Clin Ophthalmol,2009,3:41-47. 被引量:1

二级参考文献22

  • 1Snyder DA, Tessler HH. Vogt-Koyanagi-Harada syndrome [J].Am J Ophthalmol, 1980,90( 1 ) :69-75. 被引量:1
  • 2Read RV, Holland G, Rao NA, Tabbara KF, Ohno S, Arellanes- Garcia L, et al. Revised diagnostic criteria for Vogt-Koyanagi- Harada disease: report of an international committee on nomen- clature [ J ]. Am J Ophthalmol, 2001,131 ( 5 ) :647-652. 被引量:1
  • 3Rao NA. Pathology of Vogt-Koyanagi Harada disease [ J ]. Int Ophthalmol,2007,27 ( 2-3 ) :81-85. 被引量:1
  • 4Chee SP, Jap A, Cheung CM. The prognostic value of angiogra- phy in Vogt-Koyanagi-Harada disease [ J ]. Am J Ophthalmol, 2010,150(5) :888-893. 被引量:1
  • 5Arellanes-Garcia L, Hem6ndez-Barrios M, Fromow-Guerra J, Cervantes-Fanning P. Fluorescein flmdus angiographic findings in Vogt-Koyanagi-Harada syndrome [ J ]. Int Ophthalmol, 2007, 27(2-3) :155-161. 被引量:1
  • 6Yang P, Ren Y, Li B, Fang W, Meng Q, Kijlstra A. Clinical charac- teristics of Vogt-Koyanagi-Harada syndrome in Chinese patients [ J]. Ophthalmology ,2007,114 ( 3 ) :506-514. 被引量:1
  • 7Sugita S, Takase H, Taguchi C, Imai Y, Kamoi K, Kawaquchi T, et al. Ocular infiltrating CD4 + T cells from patients with Vogt- Koyanagi-Harada disease recognize human melanocyte antigens [ J ]. Invest Ophthalmol Vis Sci, 2005,47 ( 6 ) : 2547-2554. 被引量:1
  • 8Bouchenaki N, Herbort CP. The contribution of indocyanine green angiography to the appraisal and management of Vogt- Koyanagi-Harada disease [J].Ophthalmology, 2001,108 ( 1 ) : 54- 64. 被引量:1
  • 9Herbort CP, Mantovani A, Bouchenaki N. Indocyanine green an- giography in Vogt-Koyanagi-Harada disease : angiographic signs and utility in patient follow-up [J].Int Ophthalmol,2007,27 (2- 3) : 173-182. 被引量:1
  • 10Fardeau C, Tran TH, Gharbi B, Cassoux N, Bodaghi B, LeHoang P. Retinal fluorescein and indocyanine green angiography and optical coherence tomography in successive stages of Vogt-Koy- anagi-Harada disease [J].Int Ophthalmol, 2007,27 ( 2-3 ) : 163- 172. 被引量:1

共引文献7

同被引文献3

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部